Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors

Triple-negative breast cancer (TNBC) is the most refractory subtype of breast cancer and disproportionately accounts for the majority of breast cancer related deaths. Effective treatment of this disease remains an unmet medical need. Over the past several decades, TNBC cell lines have been used as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulaiman, Andrew, Wang, Lisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762590/
https://www.ncbi.nlm.nih.gov/pubmed/29348905
http://dx.doi.org/10.18632/oncotarget.22916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762590/
https://www.ncbi.nlm.nih.gov/pubmed/29348905
http://dx.doi.org/10.18632/oncotarget.22916

Ejemplares similares